MiMedx Group Inc (MDXG)

7.92 -0.32 (-3.883%)

IEX Real-Time Price

April 26, 2018 EST.

NASDAQ Capital Market : Healthcare

Prev Close 8.24

Price Open 8.22

Volume: 2.88M

Avg Volume: 2.34M

Market Cap: 879.4M

P/E Ratio -

52 Wk Range 6.05-18.25



MDXG Short Interest Statistics


Report Date
Float Share
Short Interest
Short Ratio
Short % to Float

2018-04-13
97.51M
49.07M
19.88
50.33%

2018-03-29
97.51M
49.15M
16.71
50.40%

2018-03-15
97.37M
44.23M
7.17
45.43%

2018-02-28
97.37M
39.83M
7.34
40.91%




MDXG Earning Report


Report Date
Fiscal Period
Announce Time
Estimated EPS(#)
Actual EPS
Surprise Dollar

2018-04-05
Q4 2017
N/A
0.11 (1)
0.00
0.00

2018-03-29
Q4 2017
N/A
0.00 (0)
0.00
0.00

2018-03-22
Q4 2017
N/A
0.00 (0)
0.00
0.00

2018-03-15
Q4 2017
N/A
0.00 (0)
0.00
0.00

News

MiMedx ups guidance after strong Q1 (2018-04-26 09:04 SeekingAlpha)

MiMedx Group (NASDAQ: MDXG ) boosts its 2018 revenue guidance to $389M - 394M (from $383M - 387M) after Q1 sales came in above projections. It also says it remains on track to meet its goals for gross margin (89 - 90%), operating income margin (15 - 17%), EPS ($0.30 - 0.35) and non-GAAP EP…

 

MiMedx: More Explosive Price Action Might Soon Be Here (2018-04-26 08:59 SeekingAlpha)

MiMedx Group Inc. ( MDXG ) had a very eventful day ahead of its shareholder conference call scheduled for Thursday, April 26, at 10:30 a.m. Eastern. Higher than average volume and some surprisingly positive price action highlight the risks for shorts at these depressed levels if the company'…

 

MiMedx Reports Unreviewed First Quarter Revenue Exceeded Upper End Of Its Guidance (2018-04-26 08:30 PR Newswire)

MARIETTA, Ga. , April 26, 2018 /PRNewswire/ -- MiMedx Group, Inc. (NASDAQ: MDXG), a leading developer and marketer of regenerative and therapeutic biologics, today announced certain unreviewed results for the first quarter of 2018, announced its revenue guidance for the second quarter of …

 

MIMEDX 24 HOUR DEADLINE ALERT: Approximately 24 Hours Remain; ClaimsFiler Reminds Investors of Deadline in Class Action Lawsuit Against MiMedx Group Inc. - MDXG (2018-04-24 22:50 Business Wire)

ClaimsFiler, a FREE shareholder information service, reminds investors that they have only until April 25, 2018 to file lead plaintiff applications in securities class action lawsuits against MiMedx Group Inc. (NasdaqCM: MDXG). Investor losses must relate to purchases of the Company’…

 

By The Numbers: Healthcare Stocks With Big Cash Distributions (2018-04-24 14:28 SeekingAlpha)

The healthcare sector offers many attractive characteristics for investors. Health is a priority for most people around the world, so consumers are willing to pay considerable sums of money for drugs and treatments that can make a material difference in their quality of life. An aging populati…

 


Statistics

Shares Outstanding: 111.03M

Top 15 Institution Percent: 80.80

Price To Sales: 5.12

Price To Book: 5.79

Revenue: N/A

Gross Profit: N/A

Cash: N/A

Debt: N/A

Return On Assets: 19.18

Return On Equity: 26.05

Profit Margin: 16.33

Price History

Beta: 1.52

50-day Moving Avg: 7.98

200-day Moving Avg: 12.35

YTD Change: -36.52

5-day Change: 13.03

1-month Change: 13.66

3-month Change: -52.12

6-month Change: -32.62

1-year Change: -25.77

Revenue Per Share: 0.00

Revenue Per Employee: 0.00



Dividend

Dividend Yield: -

EX-Dividend Date: -

Dividend Rate: -


Company Profile

Name: MiMedx Group Inc

Exchange: NASDAQ Capital Market

Industry: Medical Devices

Sector: Healthcare

Website: http://www.mimedx.com

MiMedx Group Inc is a developer, manufacturer and marketer of patent-protected regenerative biomaterial products and bioimplants processed from human amniotic membrane.